Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,821
Closed -$475K 163
2024
Q4
$475K Sell
1,821
-53
-3% -$15.7K 0.07% 97
2024
Q3
$604K Hold
1,874
0.09% 87
2024
Q2
$586K Buy
1,874
+883
+89% +$259K 0.09% 88
2024
Q1
$282K Sell
991
-153
-13% -$44.8K 0.05% 106
2023
Q4
$329K Hold
1,144
0.06% 100
2023
Q3
$307K Hold
1,144
0.06% 102
2023
Q2
$254K Buy
1,144
+102
+10% +$23.7K 0.05% 109
2023
Q1
$252K Buy
1,042
+6
+0.6% +$1.47K 0.05% 109
2022
Q4
$272K Hold
1,036
0.06% 102
2022
Q3
$234K Hold
1,036
0.05% 111
2022
Q2
$252K Hold
1,036
0.05% 112
2022
Q1
$251K Sell
1,036
-13
-1% -$2.99K 0.05% 126
2021
Q4
$236K Buy
1,049
+40
+4% +$8.44K 0.04% 144
2021
Q3
$215K Buy
1,009
+20
+2% +$4.6K 0.04% 140
2021
Q2
$241K Sell
989
-213
-18% -$52.4K 0.05% 135
2021
Q1
$299K Sell
1,202
-165
-12% -$39.4K 0.06% 120
2020
Q4
$314K Buy
1,367
+3
+0.2% +$692 0.07% 109
2020
Q3
$347K Buy
1,364
+348
+34% +$86.2K 0.08% 99
2020
Q2
$240K Hold
1,016
0.06% 119
2020
Q1
$206K Hold
1,016
0.06% 116
2019
Q4
$245K Buy
+1,016
New +$224K 0.05% 120
2019
Q1
Sell
-1,045
Closed -$203K 110
2018
Q4
$203K Buy
+1,045
New +$204K 0.06% 100

Other funds holding AMGN

Camden National Bank's AMGN Position: Q1 2025 in Review

Camden National Bank sold out of Amgen (AMGN) in Q1 2025, closing a stake of 1,821 shares — an estimated $475K sold.

Camden National Bank first reported a position in AMGN in Q4 2018 and held it in 22 quarters. The position peaked at $604K in Q3 2024. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Camden National Bank reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Camden National Bank sold 1,821 Amgen shares in Q1 2025, an estimated $475K.
  • Camden National Bank first reported a position in Amgen in Q4 2018 and held it in 22 quarters.
  • Camden National Bank's Amgen position peaked at $604K in Q3 2024.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Camden National Bank's 13F filing for Q1 2025, filed 13 May 2025.